The efficacy and safety of mizoribine for maintenance therapy in patients with myeloperoxidase anti-neutrophil cytoplasmic antibody (MPO-ANCA)-associated vasculitis: the usefulness of serum mizoribine monitoring.
Kaori MaseChie SaitoJoichi UsuiYoshihiro ArimuraKosaku NittaTakashi WadaHirofumi MakinoEri MusoNobuhito HirawaMasaki KobayashiWako YumuraShouichi FujimotoNaoki NakagawaTakafumi ItoYukio YuzawaSeiichi MatsuoKunihiro YamagataPublished in: Clinical and experimental nephrology (2022)
There was no significant difference in the recurrence rate of MPO-AAV between treatment with versus without MZR.
Keyphrases